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ABSTRACT The bacterial PEP:sugar PTS consists of a cascade of several proteins involved in the uptake and phosphorylation
of carbohydrates, and in signal transduction pathways. Its uniqueness in bacteria makes the PTS a target for new antibacterial
drugs. These drugs can be obtained from peptides or protein fragments able to interfere with the ﬁrst reaction of the protein
cascade: the phosphorylation of theHPr by the ﬁrst enzyme, the so-called enzymeEI. To that end, wedesigned a peptide, HPr9–30,
spanning residues 9 to 30 of the intact HPr protein, containing the active site histidine (His-15) and the ﬁrst a-helix of HPr of
Streptomyces coelicolor, HPrsc. By using ﬂuorescence and circular dichroism, we ﬁrst determined qualitatively that HPrsc and
HPr9–30 did bind to EIsc, the enzyme EI from S. coelicolor. Then, we determined quantitatively the binding afﬁnities of HPr9–30 and
HPrsc for EIsc by using ITC and STD-NMR. The STD-NMR experiments indicate that the epitope region of HPr9–30 was formed by
residues Leu-14, His-15, Ile-21, andVal-23. The binding reaction between EIsc andHPrsc is enthalpy driven and in other species is
entropy driven; further, the afﬁnity of HPrsc for EIsc was smaller than in other species. However, the afﬁnity of HPr9–30 for EIsc was
only moderately lower than that of EIsc for HPrsc, suggesting that this peptide could be considered a promising hit compound for
designing new inhibitors against the PTS.
INTRODUCTION
Bacterial pathogens are becoming resistant to the different
antibiotics used to treat infectious diseases, a problem that is
now becoming endemic worldwide (1). The majority of the
antibiotics used today were discovered in the 1950s and
1960s. The pharmaceutical industry has been, since then,
occupied in improving the activity of such compounds and in
making them completely refractory to any resistance mech-
anism. During the 1990s, research into the bacterial genome
triggered a resurgence of drug discovery with the use of high-
throughput screening tools to identify new antibiotics.
However, although many enzyme inhibitors have been dis-
covered, only a few of them inhibit bacterial growth, and of
those few, a small fraction has gone through clinical testing
(2). On the other hand, during the same period of time, the
analysis of bacterial genomes has led to important discoveries
in the identiﬁcation and interconnections of some metabolic
pathways. The bacterial PEP?-dependent sugar PTS is one of
those: it is a multiprotein complex system that mediates the
uptake and phosphorylation of carbohydrates and is involved
in signal transduction (3,4). This system is present in bacteria
but does not exist in animals or plants; thus, both its unique-
ness and its involvement in several regulation steps make the
PTS proteins essential for the bacterial survival and an ideal
target for possible new antibacterial drugs (3,4).
The PTS involves a cascade of phosphoryl-transfer steps
from PEP to sugar-speciﬁc enzyme II permeases via phos-
phointermediates of the general cytosolic non-sugar-speciﬁc
phosphotransferase EI and HPr. EI, a dimeric protein, is
autophosphorylated on a histidine residue by PEP (5), and
then, the phosphoryl group is transferred to HPr. EI is one of
the best conserved proteins in the prokaryotic kingdom, and it
has no similarity to eukaryotic proteins. The non-sugar-
speciﬁcity of EI and HPr makes both proteins excellent tar-
gets to control the function of the PTS; thus, any compound
able to inhibit EI should interrupt the ﬂow of phosphoryl
groups along the cascade and, concomitantly, the use of HPr
in the utilization of alternative carbon sources (3). Our aim is
to design peptides or protein fragments derived from HPr
able to interrupt the phosphorylation step with EI.
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Streptomyces is a soil-dwelling actinomycete that grows
on a variety of carbon sources. These actinomycetes are at the
origin of approximately two-thirds of all natural antibiotics
currently produced by the pharmaceutical industry. The
complete genome of Streptomyces coelicolor has been se-
quenced, and it shows the largest number of genes found in
any bacteria (6). The presence of the different components of
the PTS in S. coelicolor has been reported, and the corre-
sponding proteins have been cloned and expressed (7,8).
There is a large homology between these PTS proteins and
those of other antibiotic-resistant species, such as Vibrio
cholerae and Streptococcus pneumoniae (3,7,8). We have
undertaken an extensive description of the structures and
conformational stabilities of the HPrsc and EIsc proteins (9–
12). HPrsc is a single polypeptide chain of 93 amino acids; it
lacks cysteine and tyrosine residues, and it has one trypto-
phan and one phenylalanine. The structures of HPr proteins
from several species have been described by NMR (13,14)
and x-ray (15,16), and the NMR assignments of HPrsc indi-
cate that its structure is similar to that observed in other
members of the HPr family (J. L. Neira, unpublished results).
The regions of HPrec involved in the binding to EIec are the
ﬁrst two a-helices as well as the loop preceding the ﬁrst
a-helix and the turn after the second a-helix, as shown by
x-ray and NMR studies of the protein complex (17,18).
In this article, we describe the binding of a peptide derived
from HPrsc (HPr9–30), containing the active-site histidine, to
EIsc. We have also tested the binding of the intact HPrsc to
EIsc to allow comparison with the values obtained with the
peptide and with the afﬁnities measured in other species (19–
21). The afﬁnity was measured by using two biophysical
techniques, namely, STD-NMR and ITC. The two techniques
provided identical results when a ﬁnal EIsc concentration of
;10 mM was used: the apparent dissociation constants were
in the range of hundreds of micromolar. Both techniques
qualitatively agree in that the afﬁnity of HPr9–30 for EIsc was
slightly lower than that of HPrsc, although it contains only 22
residues of the intact protein. We can also conclude, based on
the NMR results, that most of the residues of the intact HPrsc
implicated in the binding to EIsc are also involved in the
binding of EIsc to HPr9–30, which interestingly becomes
helical on binding. Further, on the basis of ITC experiments
and on the value of the afﬁnity constant, we can conclude that
the peptide can be used as a hit compound to design new
antibiotics, whose activity should also be checked in other
species.
MATERIALS AND METHODS
Materials
Imidazole, Trizma acid, Trizma base, TFE, NaCl, and TSP were from Sigma
(St. Louis, MO). b-Mercaptoethanol was from BioRad (Hercules, CA), and
the Ni21 resin was from Invitrogen (Carlsbad, CA). Standard suppliers were
used for all other chemicals. Water was doubly deionized and puriﬁed on a
Millipore (Billerica, MA) system.
Puriﬁcation of HPrsc and EIsc
The HPrsc clone, comprising residues 1 to 93, was kindly provided by Dr. F.
Titgemeyer (Erlangen, Germany). The cloning vector contains a His6-tag at
the N-terminus end in frame with the ﬁrst methionine (Met-1) of the protein.
The stability and the structure of the His-tagged protein are the same as those
of the cleaved protein (10). Protein was puriﬁed as described (9).
The EIsc clone was also kindly provided by Dr. F. Titgemeyer. The
cloning vector contains a His6-tag at the N-terminus end in frame with the
Met-1 of the protein. The EIsc protein is 576 residues long, and we assumed
that the His6-tag did not alter the binding properties of the enzyme. Protein
was puriﬁed as described (12).
Protein concentrations were calculated from the absorbance of a stock
solution measured at 280 nm, using the extinction coefﬁcients of model
compounds (22).
Peptide design and synthesis
The HPr9–30 peptide (Ac-GWAEGLHARPASIFVRAATATG-CONH2) was
derived from HPrsc, spanning residues Gly-9 to Ala-30. Those amino acids
belong to the ﬁrst a-helix of HPrsc (residues Ala-16 to Thr-27) plus the
preceding loop containing the active-site histidine and three ﬂanking residues
on each side to avoid fraying effects. The N- and C-termini were acetylated
and amidated, respectively, to avoid charge effects. The peptide was pur-
chased from Zinsser Analytic (Frankfurt, Germany). The CAC peptide (see
below) was purchased from Zinsser Analytic, and the two other peptides
were obtained from Isogen Life Science (I Jsselstein, The Netherlands).
Purity was assessed in all cases by mass spectrometry (MALDI-TOF) and
HPLC chromatography and found to be larger than 95%. Peptide concen-
trations were determined by using the absorbance of the tryptophan or ty-
rosine residues present in each peptide (22).
Circular dichroism measurements
Although the optimum pH for the binding reaction is unknown, we carried
out our quantitative and qualitative measurements at pH 7, similar to the pHs
used in the binding of EI to HPr in other species (19–21).
Spectra were collected on a Jasco J810 (Tokyo, Japan) spectropolarimeter
ﬁtted with a thermostated cell holder and interfaced with a Peltier. The in-
strument was periodically calibrated with (1)-10-camphorsulfonic acid. Far-
UV steady-state spectra were acquired at a scan speed of 50 nm/min with a
response time of 4 s and averaged over four scans at 298 K. Spectra were
acquired in a 0.1-cm-pathlength cell (Hellma, Plainview, NY), and they were
corrected with the proper baseline. The samples were prepared in 100 mM
Tris buffer (pH 7). The EIsc, HPrsc, and HPr9–30 concentrations were 4 mM,
10 mM, and 10 mM, respectively.
Fluorescence measurements
Fluorescence spectra were collected in a Cary Eclipse spectroﬂuorometer
(Varian, Palo Alto, CA) interfaced with a Peltier-thermostated multicell
holder. The slit widths were 5 nm for both excitation and emission wave-
lengths. Excitation wavelengths were 280 and 295 nm; both wavelengths
yielded the same results (data not shown). The signal was acquired every 1 s,
and the wavelength increment was 1 nm. Experiments were acquired at 298
K, in a 1-cm-pathlength quartz cell (Hellma). The EIsc concentration was 2
mM in buffer Tris (100 mM), and 2 mM of either HPr9–30 or HPrsc was added
in each experiment.
Attempts to determine the afﬁnity constant by either CD or ﬂuorescence
failed because of the small afﬁnity constant (see below).
Quenching experiments aimed at detecting protein self-association of EIsc
under the protein concentrations used in this work were carried out as de-
scribed (12). The EIsc protein concentration was varied from 0.5 to 15 mM at
pH 7 (50mMTris buffer).We have assumed that the dominant species in EIsc
is a monomer and/or a dimer, as in other EI proteins.
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NMR spectroscopy
All NMR experiments were acquired at 283 K on an Avance Bruker DRX-500
spectrometer equippedwith a triple resonance probe and z-pulse ﬁeld gradients.
Homonuclear one- and two-dimensional NMR experiments were per-
formed at pH 7, 50 mM phosphate buffer (uncorrected for deuterium isotope
effects) in H2O/D2O (90%/10% v/v). TSP was used as the external chemical
shift reference in the homonuclear experiments.
Two-dimensional NMR spectra of HPr9–30 (1 mM) in the presence of 8.6
mM of EIsc were recorded in the phase-sensitive mode by using the States-
TPPI method (23). All experiments were carried out with theWATERGATE
pulse sequence for water suppression (24). Two-dimensional 1H-1H TOCSY
spectra were recorded by using an MLEV-17 spin-lock sequence (25) with a
mixing time of 80ms. NOESY experiments were recorded with mixing times
of 100 and 250 ms. Typically, spectra were acquired with 512 t1 increments,
2048 data points, and a relaxation delay of 1 s. The spectral width was 6000
Hz in all cases. The spectra were processed using the BRUKER-XWINNMR
software on a PC workstation. All spectra were zero-ﬁlled in the indirect
dimension to 1024 data points, and a square sine bell window function was
applied in both dimensions before Fourier transformation. Sequential as-
signments of the proton resonances of isolated HPr9–30 have been previously
described (26). Assignments of the peptide were not modiﬁed in the presence
of EIsc under any of the conditions explored (in a concentration range of
HPr9–30 from 12 to 250 mM).
In the STD experiments, a certain volume from a stock solution of the
peptide (not larger than 5 mM) or the intact HPrsc was dissolved in 500 mL of
a solution containing EIsc in 50 mM phosphate buffer (pH 7.0). Then, the
HPr9–30:EIsc or HPrsc:EIsc protein ratio was varied in each experiment by
keeping constant the concentration of EIsc. The one-dimensional 1H-STD-
NMR (27–29) spectra of the HPr9–30:EIsc and HPrsc:EIsc complexes were
recorded with 4000 to 8000 scans. Selective saturation of protein resonances
was set at 3 ppm (on resonance); control experiments at this frequency
showed that the entire protein can be saturated uniformly and then efﬁciently
used for the STD-NMR technique; furthermore, this frequency is far away
from themost upﬁeld-shiftedmethyl protons of either HPrsc or theHPr9–30, such
that no perturbation of these signals occurred by the selective shaped pulse.
The time dependence of the saturation transfer with saturation times
ranging from 0.2 to 2.5 s showed that at least 1.5 s was needed for efﬁcient
saturation transfer from the EIsc protein to the ligand (HPrsc or HPr9–30)
protons (see Results). STD-NMR spectra were acquired by using a series of
equally spaced 50-ms Gaussian-shaped pulses for selective saturation (30).
The radio-frequency ﬁeld strength of the Gaussian-shaped pulses was;100
Hz, with a 1 ms delay between the pulses. Residual water signal was elim-
inated by using excitation-sculpting procedures (31). A spin-lock sequence
was applied before the excitation-sculpting sequence to remove the signals of
the EIsc protein (32). The reference STD spectra were recorded with the off-
resonance set at 30 ppm. Saturated spectra were subtracted from the reference
spectra via phase cycling.
The following controls were carried out to ensure that the STD effects
observedwere caused by real saturation of EIsc. STD-NMR experiments with
on- and off-resonance frequencies set at 3 and 30 ppm, using a saturation
time of 2 s, were carried out on isolated HPr9–30 at 2 mM concentration. No
signals were present in the difference spectra, indicating that the effects
observed in the presence of EIsc resulted from true saturation transfer. Similar
control experiments were carried out in a sample containing HPrsc, where the
most up-ﬁeld-shifted protons appear at 0.4 ppm (J. L. Neira, unpublished
results). No signals were present in the difference spectra.
To further check that the measured values of the dissociation constants
were not caused by the absence of the protein phosphorylation, control STD
experiments were also carried out in the presence of 2 mM PEP, 4 mM
MgCl2 (the natural effectors of EI
sc), and 100 mM of HPr9–30 (pH 6.8,
phosphate buffer) or 100 mM of HPrsc. No differences were observed in the
signal intensity of selected protons when compared to those in the absence of
the effectors (data not shown).
Because the afﬁnity constant of the peptide was very small (see Results),
we carried out three controls, with different peptides to rule out any possi-
bility of unspeciﬁc binding of HPr9–30 to EIsc. The ﬁrst peptide was identiﬁed
in a phage display study against EIec as being able to inhibit the growth of
E. coli strains (33); its sequence is GLRFGKTRVHYLVLG-NH2. The
second peptide is able to bind to thioredoxin m from pea, and it is derived
from the pea chloroplast fructose-1,6-biphosphatase; its sequence is ESLP-
DYGDDSDDNTLGTEEQRSIVNVSQ-NH2. The last peptide comes from
the protein forming the capsid of HIV, and it has been able to dissociate the
dimeric wild-type protein (34); its sequence is: Ac-EQASQEVKNWM-
TETLLVQNA-NH2. The on- and off-frequencies, and the rest of the pa-
rameters in the STD experiments were the same as those used with the HPr
ligands. The EIsc concentration was 12 mM, and the corresponding peptide
concentration was;2 mM in the three controls. The saturation time was 2 s
in the three peptides.
To allow for comparison among the STD experiments, the signal inten-
sities of the different protons were analyzed by the use of the fractional STD
ampliﬁcation factor, STDaf, which expresses the signal intensity in the STD
spectrum, I0 Isat, as a fraction of an unsaturated reference spectrum, I0, and
the excess of added HPrsc or HPr9–30 peptide (27,28):
STD amplification factorðSTDaf Þ
¼ I0  Isatð Þ
I0
3 ½HPriexcess;
where [HPri] is the concentration of either HPrsc or HPr9–30 in each
experiment. For the experiments with HPr9–30 the concentration of EIsc
was 8.6 mM (in monomer units), and for those with the intact HPrsc, the EIsc
concentrationwas 10.3mM (inmonomer units). The errors in the STDafwere
estimated from the determination of the STD effects measured in two
identical samples at 1.5 s and processed simultaneously. The differences
obtained were lower than 5% for all the measured resonances.
The apparent dissociation constant, KD, was obtained by ﬁtting the
STDaf versus the concentration of added HPr9–30 or HPrsc to:
STDafmeas ¼ STDaf 01DSTDafmax

ð½EI1 ½HPri1KDÞ

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½EI1 ½HPri1KDÞ2  4½EI½HPri
q 
;
where STDafmeas is the STDaf measured at any particular concentration of
HPrsc or HPr9–30; STDaf 0 is the value of the STDaf in the absence of HPrsc or
the peptide; STDafmax is the maximum of the STD effect; and [EI] is the
concentration of EIsc in the monomeric form (8.6 mM or 10.3 mM).
Fitting of data to the binding equation was carried out by a least-squares
analysis using the program Kaleidagraph (Abelbeck software, Reading, PA)
on a PC computer.
Isothermal titration calorimetry
ITC measurements were performed by using a VP-ITC isothermal titration
calorimeter (Microcal, Northampton, MA). Measurements were carried out
at 298K. Sample cell (1.4 mL) was loaded with EIsc at 20mM; either HPrsc or
HPr9–30 was loaded into the syringe at a total concentration of 300 mM.
Twenty-eight injections of 10 mL were added sequentially to the sample cell
after 400 s to ensure that the titration peak returned to the baseline before the
next injection. The amount of power required to maintain the reaction cell at
constant temperature after each injection wasmonitored as a function of time.
The obtained isotherms (differential heat upon binding versus the molar
ratio: [HPri]/[EI]) were ﬁtted to a single-site model assuming that the com-
plex with EIsc had a 1:1 stoichiometry (as described in other species (19)).
Data were analyzed with software developed in our laboratory, implemented
in the software package Origin 7.0 (Microcal). As a control experiment, the
individual dilution heats for the intact HPrsc were determined under the same
experimental conditions by carrying out identical injections of the HPrsc into
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the sample cell, which contained only buffer. These control injections elic-
ited no signiﬁcant heat.
Experiments were carried out in two buffers to analyze the contribution of
the buffer ionization enthalpy: 1), 12 mM Tris, pH 7.4, and 100 mM NaCl;
and 2), 12 mM MOPS, pH 7.4, and 100 mM NaCl. Then, the apparent en-
thalpy change, DHmeas, buffer, in the corresponding buffer is (35):
DHmeas; buffer ¼ DH01 nHDHion;
where DH0 is the buffer-independent binding enthalpy, DHion is the ioniza-
tion enthalpy of the buffer, and nH is the number of exchanged protons
between the complex and the solvent during the binding reaction.
RESULTS
Binding of EIsc to HPr9–30 and HPrsc monitored by
ﬂuorescence and CD
The spectrum of EIsc is characterized by an intense maximum
at 335 nm (after excitation at either 280 or 295 nm), and its
CD spectrum shows the features of an a 1 b helical protein
(11,12). The ﬂuorescence spectrum of HPrsc shows also a
maximum at 335 nm (after excitation at either 280 or 295
nm), as well as the features of an a1 b helical protein in the
far-UV CD (9). Conversely, the ﬂuorescence spectrum of
HPr9–30 shows a maximum at 350 nm, and the CD spectrum
resembles that of a random coil (26).
We carried out binding measurements by using steady-
state ﬂuorescence and CD with EIsc and intact HPrsc;
differences were observed among the addition (CD or
ﬂuorescence) spectra and those of the corresponding
complexes. The CD spectrum of HPrsc (10 mM) in the
presence of 4 mM of EIsc is shown in Fig. 1 B. The spec-
trum corresponding to the addition of the spectra of EIsc
and HPr9–30 is also different to that of the complex (Fig.
1 D). A similar behavior was observed when the emission
ﬂuorescence spectrum of the complex between EIsc and
HPr9–30 was compared with the addition spectrum ob-
FIGURE 1 Binding of EIsc to HPrsc andHPr9–30 measured by CD and ﬂuorescence. (A) Fluorescence spectrum of the complex formed byHPrsc and EIsc (light
gray) and that obtained by the addition of the spectra of both isolated species (dark gray). (Inset) Fluorescence spectra ofHPrsc, EIsc, andHPr9–30; the units on the y
axis are arbitrary and cannot be compared with those of the main ﬁgure. (B) Far-UV CD spectrum of the complex formed by HPrsc and EIsc (light gray) and that
obtained by the addition of the spectra of both isolated species (dark gray). (Inset) Far-UV CD spectra of HPrsc, EIsc, and HPr9–30; the units on the y axis are
arbitrary and cannot be compared with those of the main ﬁgure. (C) Fluorescence spectrum of the complex formed by HPr9–30 and EIsc (dark gray) and that
obtained by the addition of the spectra of both isolated species (light gray). (D) Far-UVCD spectrum of the complex formed by HPr9–30 and EIsc (dark gray) and
that obtained by the addition of the spectra of both isolated species (light gray). Conditionswere 100mM (phosphate buffer, pH 7) at 298K, 2mMEIsc, and 2mM
of the corresponding ligand for the ﬂuorescence spectra; similar results were obtained by excitation at 295 nm. In the far-UV experiments, the spectra were
acquired at 278 K to increase the percentage of helical population in HPr9–30, in 100 mM Tris buffer, pH 7, 4 mM EIsc and 10 mM of the corresponding ligand.
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FIGURE 2 Binding of EIsc to HPrsc measured by STD-
NMR. (A) STD-NMR spectra at different saturation times,
from bottom to top: reference spectrum (bottom), STD
spectrum at 1 s of saturation (middle), and at 2 s of
saturation (top). (B) The rate between the methyl peak
intensity in the STD spectra and that at the reference
spectrum at 20.8 mM (open squares), and at 135.20 mM
of HPrsc (solid squares) are shown. (C) Binding curves for
the STDaf of the methyl signals in HPr at 2 s of saturation
time. The curve is the ﬁtting of data to the equation of
STDaf. Conditions were: 10.3 mM of EIsc at 283 K.
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tained by the sum of each isolated polypeptide chain (Fig.
1 C). These results suggest that, at least from a qualitative
point of view, there is binding between either HPr9–30 or
HPrsc, and EIsc. Taking into account the afﬁnity constant
determined by ITC and STD (see below), the amount of
formed complex under these conditions should be ;10%
in both HPr polypeptides, which should explain the dif-
ferences observed.
To rule out the presence of a substantial amount of mono-
meric EIsc species under our conditions, we monitored its self-
association by using ﬂuorescence quenching experiments and
gel ﬁltration measurements. We observed that at physiological
pH, as the concentration of protein was increased, the value of
Ksv (the Stern-Volmer constant) decreased: 1.3 6 0.1 (at 0.5
mM), 0.966 0.07 (at 1mM), 0.926 0.03 (at 2mM), 0.86 0.1
(at 4 mM of EIsc), as previously reported (12); and, 0.85 6
0.05 (at 8 mM), 0.816 0.03 (at 10 mM), and 0.796 0.05 (at
15 mM), as found in the extended range of explored protein
concentrations in this work.We also carried out experiments at
15 mM of EIsc of protein concentration by using an analytical
gel ﬁltration column (Superdex 200 HR10/30, GEHealthcare,
Piscataway, NJ), where the protein eluted at volumes corre-
sponding to a molecular mass of 160 kDa (data not shown).
Thus, under the conditions used in the CD, ﬂuorescence, STD,
and ITC measurements (see below), EIsc remained dimeric.
Binding of EIsc to HPr9–30 and HPrsc monitored
by STD-NMR
We ﬁrst measured the STD effects between EIsc and HPrsc by
observing the methyl region of HPrsc (Fig. 2 A). Saturation
times of 1.5 s were needed to fully saturate the upﬁeld-shifted
region of the protein (Fig. 2 B). The dissociation constant
obtained by using different saturation times was 956 30 mM
(Fig. 2 C). This value was an order of magnitude higher than
that obtained for binding of EI to HPr in E. coli (20,21), orM.
capricolum (19). Because of spectral overlapping in the one-
dimensional STD-NMR experiments and the absence of a
complete assignment of the resonances of the intact protein,
we could not identify the particular protons involved in the
binding region.
Conversely, in HPr9–30, we were able to identify which
protons showed STD effects. The STD effects were observed
in D2O for the C2H and C4H protons of the His-15 (using the
numbering of the intact protein) and the aromatic protons of
Phe-22, which partially overlapped with those of Trp-10. The
methyl protons of Leu-14, Ile-21, and Val-23 also showed
intense STD effects, although we could not discriminate
which methyl group (Fig. 3 A). As with HPrsc, saturation
times of 1.5 s were necessary to achieve a full protein signal
saturation (Fig. 3 B). Among all protons experiencing satu-
ration effects, the methyl groups showed the largest variation,
and consequently, they were used to determine the KD (Fig. 3
C). The obtained value for the KD was 4206 90 mM, which
was larger than that obtained for HPrsc (see above).
It could be thought that the absence of the effectors would
alter the afﬁnity of the peptide by EIsc. However, control
experiments, with EIsc in the presence of its effectors (4 mM
Mg21 and 2mMPEP) showed that the signals of HPr9–30 also
became broader, but there were no changes in the chemical
shifts of the backbone, nor in the side-chain protons, nor in the
magnitude of the STD effects (data not shown).
The CAC and thioredoxin control peptides did not show
any STD effects. Conversely, the peptide found by phage
display analysis (33) did show STD effects, especially with
the aromatic and the methyl protons (data not shown), sug-
gesting that even though it was designed against EIec, it could
also bind to EIsc. Thus, although the afﬁnity of HPr9–30 for
EIsc is very small, it appears to be speciﬁc.
Binding of EIsc to HPr9–30 and HPrsc monitored
by ITC
Data were analyzed by using a simple two-state model and
with a 1:1 stoichiometry, as has been reported in other
members of the HPr family (19,20) and used during analysis
of the STD data (see above). The measured apparent disso-
ciation constants agree reasonably well with those obtained
by STD-NMR experiments: 120 6 20 mM for the intact
HPrsc, and 230 6 80 mM for HPr9–30 (Fig. 4, Table 1). (It
could be thought that with those afﬁnity constants, the
complete saturation curve in the ITC experiments could be
obtained with a 1 mM stock solution of peptide instead of the
used stock solution of 0.3 mM of HPr9–30 (see Materials and
Methods). In our experience, with peptides with weak af-
ﬁnities (such as those used as controls in this work), it would
require peptide stock concentrations of 10 mM or larger to
obtain a complete saturation curve. We have observed that
the NMR spectrum of HPr9–30 at concentrations higher than 5
mM shows signiﬁcant broadening, suggesting oligomeriza-
tion reactions, whose order and equilibrium constants are
unknown; then, the use of high concentrations in the stock
peptide would require an additional reaction to estimate the
afﬁnity constant of the peptide for EIsc. CD cannot be used
either because of the large voltage in the detector at the
concentrations required during the titration. Finally, the use
of ﬂuorescence was not possible because of the self-associ-
ating properties of the peptide indicated above and the large
inner-ﬁlter effects at the concentrations needed in the ex-
periment.)
To determine the buffer-independent enthalpy of the
binding reaction, the effect of the buffer ionization heat was
taken into account by carrying out the binding reaction in two
buffers: Tris and MOPS, which have different ionization
enthalpies (11.7 and 5.5 kcal mol1, respectively). With this
procedure (35,36), the buffer-independent enthalpy of the
binding reaction DH0 was obtained, and the number of ex-
changed protons between the complex and the bulk solution,
nH, was calculated (Table 1). A positive value of nH indicates
a protonation, the uptake of a proton by the complex (such as
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FIGURE 3 Binding of EIsc to HPr9–30 measured by STD-
NMR. (A) STD-NMR spectra at different saturation times,
from bottom to top: reference spectrum (bottom), STD
spectrum at 1 s of saturation (middle), and at 2 s of
saturation (top). (B) The rate between the methyl peak
intensity in the STD spectra and that at the reference
spectrum at 46.0 mM (open squares) and at 115.0 mM of
HPrsc (solid squares). (C) Binding curve for the STDaf of
the methyl signals in HPr9–30 at 2 s of saturation time. The
curve is the ﬁtting of data to the equation of STDaf.
Conditions were: 8.6 mM of EIsc at 283 K.
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happens with the complex between EIsc and the intact
HPrsc, where the number of exchanged protons is 1); on the
other hand, a negative value of nH indicates a deprotonation,
the release of a proton from a residue in the complex (such
as in HPr9–30, where the number of exchanged protons is1).
DISCUSSION
The region of HPr9–30 that interacts with EIsc is
the same as in the intact HPr
In the solution structure of the complex between the N-ter-
minal domain of EIec and HPrec (17), there are hydrophobic
contacts involving residues in the ﬁrst a-helix of HPrec
(within parentheses the corresponding residue in HPrsc),
namely, Thr-16 (Ala-16), Arg-17, and Ala-20 (Ser-20).
Further, the side chain of Arg-17, a residue conserved in other
HPrs, is involved in salt bridges with other residues within
EIec (17). The environments of His-15, Gln-21 (Ile-21) and
Val-23 were also modiﬁed, as shown by the changes in the
chemical shifts of some of their protons (18). Similarly, the
residues of HPrec, belonging to the ﬁrst helix, that show in-
teractions with the glucose-speciﬁc enzyme IIA, are Leu-14,
Thr-16 (Ala-16), Gln-21 (Ile-21), and Val-23; and those
showing interactions with glycogen phosphorylase are Ala-
10 (Trp-10), Gly-13, Ala-19, and Ala-20 (Ser-20) (18). The
most affected regions of HPr on binding to EI or other pro-
teins, then, were clustered in the region contained in the de-
signed HPr9–30.
The most important STD effects in HPr9–30 were observed
in the side chains of Leu-14, the active-site His-15, Ile-21
(Gln-21 in HPrec), and Val-23. We could not unambiguously
detect STD effects in the rest of the aliphatic chains of the
FIGURE 4 ITC measurements. (A) HPr binding to EIsc. The top trace shows the raw data, and the lower trace is the ﬁtting after signal integration. The short
sequence of raw data is a control experiment (the last data in the upper left panel), where the individual heats of dilution for HPrsc were determined under the
same experimental conditions by making identical injections of the HPrsc solution into the titration cell, which contained only buffer. Measurements were
carried out in 12 mM Tris with 100 mM NaCl (solid squares) and 12 mM MOPS with 100 mM NaCl (open squares). (B) HPr9–30 binding to EIsc. The traces
and the buffers used are the same as those described in HPrsc.
TABLE 1 Binding parameters of the association reaction of EI
with HPr and with HPr9–30
Thermodynamic parameter HPr HPr9–30
KD (mM) * 95 6 30 420 6 90
KD (mM) 120 6 20 230 6 80
DHmea,Tris (kcal mol
1) 1.9 6 0.4 0.7 6 0.2
DHmea,MOPS (kcal mol
1) 2.5 6 0.4 5.1 6 0.4
DH0 (kcal mol1)y 6.3 6 0.6 10.2 6 0.4
DG0 (kcal mol1) z 5.4 6 0.2 4.8 6 0.2
TDS0 (kcal mol1) § 0.9 6 0.6 15.0 6 0.4
nH 0.72 0.96
As determined by ITC at 298 K; KD is the dissociation constant.
*As determined by STD-NMR at 283 K. The values shown are the average
of the dissociation constant obtained at saturation times of 2.5, 2, 1.5, and
1 s; the error is the standard deviation.
yIt is the value of the enthalpy for the binding reaction.
zDetermined as DG0 ¼ RTlnKD. The average of the values obtained by
STD-NMR and ITC measurements is reported.
§Determined as TDS0 ¼ DG0  DH0.
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residues affected because severe overlapping exists in the
alkyl region (26). However, from the above pieces of evidence,
we suggest that HPr9–30 acquires a native-like conformation
on binding to EIsc because otherwise those residues could not
show the STD effects measured (vide infra).
The afﬁnity of HPr9–30 for EIsc is smaller than that
of the intact HPrsc
The observed dissociation constant for HPr9–30 was only two-
and-a-half times larger than that of the intact HPrsc (Table 1),
as shown by ITC and STD-NMR measurements. The ob-
served binding afﬁnity for the HPr9–30 is an apparent binding
constant modulated by the conformational change toward a
native a-helical conformation coupled to the binding process.
The HPr9–30 fragment is disordered in solution (26), and it
must adopt (as suggested by the STDs) a native-like confor-
mation when it binds to EIsc, resulting in a free energy penalty
associated with such a conformational transition. From TFE
conformational equilibrium experiments of HPr9–30 (26), a
free energy difference of 2.7 kcal mol1 in aqueous solution
has been estimated between the disordered and its native-like
helical structure; this value yields an equilibrium constant of
K¼ [N]/[U]¼ 0.011 for the conformational change, where N
is the helical native-like conformation, and U is the unfolded
conformation of the peptide. (This equilibrium constant is
obtained by using the linear extrapolation method in the
changes of the ellipticity at 222 nm of HPr9–30 as TFE con-
centration is varied. Thus, the free energy of the peptide
folding reaction (U/)N) follows DG ¼ DG0 1 m [TFE],
where DG0 is the free energy of the reaction in the absence of
TFE (see Hurtado-Go´mez et al. (26) for details).) The ap-
parent binding constant is equal toKL/(11K
1), whereKL is
the intrinsic binding constant in the absence of the coupled
conformational equilibrium in the peptide. Therefore, the
observed binding afﬁnity should be corrected by a factor of 90
or slightly less to estimate the intrinsic binding afﬁnity of the
fragment (it would be lower if the isolated HPr9–30 showed
some residual structure, which could be too fast to be detected
byNMR techniques). Conversely, binding betweenHPrsc and
EIsc should not result in large conformational changes, as
shown by the NMR structures of the complex in E. coli
(17,18). Then, the intrinsic binding afﬁnity of the fragment
appears to be higher than that of the intact HPrsc, and there-
fore, HPr9–30 may represent an excellent template for ligand
optimization. This result is somewhat surprising because the
peptide contains only 22 residues of the intact protein, but it is
encouraging because it proves thatmost of the crucial residues
for binding are those contained in the fragment. With the
phage display, several peptides designed against EIec have
shown cell growth inhibition (33), but no clue about the
corresponding mechanism has been provided. The peptides
share similar residues with HPr9–30, and we suggest that the
inhibition of the whole PTS system in vitro by the phage
peptides results from interaction with EI.
On the other hand, the buffer-independent binding en-
thalpies and the number of exchanged protons are also
markedly different when intactHPrsc andHPr9–30 bind to EIsc.
However, if we keep in mind the conformational changes
undergone by the small fragment when it binds to EIsc, these
differences are not unexpected. The association reaction in
HPrsc has a negative enthalpy value (Table 1); then, with that
measured KD, the entropy change to compensate DG should
be small and negative; that is, the reaction should be enthalpy-
driven. In contrast, whenHPr9–30 is bound to EIsc, the value of
the enthalpy is positive, suggesting that the entropy contri-
bution should be large and positive (entropy-driven). Because
the fragment acquires a native folded conformation on bind-
ing, we could explain this positive entropy value in terms of
the balance between a conformational entropy decrease and a
desolvation entropy increase on fragment folding; in addition,
other contributions to the entropy change need to be consid-
ered (such as deprotonation of ionizable groups).
Some comments, however, must be made about the ITC
experiments and their possible drawbacks. Because the
binding afﬁnity is low, the stoichiometry, n, must be ﬁxed in
the nonlinear square-ﬁtting procedure. When the afﬁnity is
low, it is not possible to estimate afﬁnity, enthalpy, and
stoichiometry independently by ITC, and a value for the
stoichiometry must be assumed. The natural election, in the
absence of additional information, is n ¼ 1; that is, there is
one binding site with a protein completely pure (as checked
by SDS-PAGE) and binding-competent. However, this is a
limitation inherent to any binding technique, not only for
ITC. In fact, the equation used to estimate the dissociation
constant by STD-NMR is the very well known and widely
employed equation for ligand binding analysis where it is
implicitly assumed that the stoichiometry is n¼ 1. Of course,
the assumption of a ﬁxed value for the stoichiometry will
condition the accuracy of the enthalpy estimation, but the
afﬁnity determined will not be much affected by the election
of the stoichiometry value. However, using the same value
for the stoichiometry in all experiments will make the en-
thalpy error homogeneous; as a rule of thumb, an error of
20% in the stoichiometry will produce an error of 20–25% in
the enthalpy of a low-afﬁnity equilibrium. Then, the dis-
cussion about the binding energetics of HPrsc and its frag-
ment is valid even with an error of 20% in the enthalpy.
The idea of estimating the buffer-independent enthalpy is
to eliminate the possible inﬂuence of the buffer on the value
of the measured enthalpy. Two buffers were employed just to
have a rough estimate of this parameter. Because the ob-
served values of the enthalpy for each buffer may be affected
by 20% error (as a result of the stoichiometry error mentioned
above), it is worthless to reﬁne the linear regression ﬁtting by
using more than two buffers. Even with the possible errors in
the enthalpy values, it is clear that the buffer-independent
enthalpy must be negative for HPr and positive for its frag-
ment, because in both cases the enthalpy determined in
MOPS and the enthalpy determined in Tris are of opposite
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sign. Something similar happens with the net number of
exchanged protons: it must be positive for HPr and negative
for its fragment.
The magnitude of the heats is fairly small, as expected for a
reactionwith low afﬁnity and low enthalpy. However, a control
experiment was carried out by injecting ligand into buffer, and
equal constant heats were obtained (shown in Fig. 4). There-
fore, the decreasing/increasing heats obtained in the titrations
with protein and ligand must reﬂect the binding process.
Thus, the ITC experiments may serve as a conﬁrmation of
the weak afﬁnity determined by STD. In addition, even tak-
ing into account certain signiﬁcant errors in the enthalpy val-
ues determined (directly measured and buffer-independent),
they make it possible to detect thermodynamic differences
in the binding of HPrsc or its fragment to EIsc (the enthalpy
value and the net number of exchanged protons are of op-
posite sign) that may reﬂect differences in the mode of
binding of both ligands. These differences are not as clear
when only the binding afﬁnities, which are not as different,
are compared.
The afﬁnity of HPrsc for its EIsc partner is smaller
than in other members of the HPr family
One of the results of this study is that in S. coelicolor, the
dissociation constant for the EIsc:HPrsc is larger (;100 mM)
than those measured in E. coli (9 mM) or M. capricolum (7
mM) (19,20). It can be thought that there are three possible
reasons to explain such discrepancy. First, because EI is a
dimer, the different amount of EI used for each species could
account for the discrepancies; however, the concentrations
used in this work were similar (10 mM) to those used in the
experiments with E. coli and M. capricolum (19,20) (;30
mM). Alternatively, because the dimerization state of EIec has
been shown recently to be exquisitely dependent on the so-
lution conditions (37), we could think that under our condi-
tions EIsc was not dimeric, and then, it could result in a lower
afﬁnity constant for HPrsc. We have previously shown that
dimerization of EIsc can be monitored by ﬂuorescence
quenching (12), and then we have extended here the range of
explored protein concentrations. The dominant EIsc species
was dimeric within the protein concentration range used in
this work (8 to 12 mM), and the lower afﬁnity for HPrsc
cannot be attributed to the presence of a signiﬁcant popula-
tion of monomeric EIsc species.
Second, the binding afﬁnity could be affected by the buffer
used in the titration. The buffers used in S. coelicolor in this
work were phosphate (for STD-NMR), MOPS, and Tris (for
ITC measurements); in other HPr species studied, the phos-
phate buffer was chosen (19–21). Because even when dif-
ferent buffers are used, the different techniques used in this
work, yield similar dissociation constants, so the discrepancy
observed among the afﬁnities in the different species cannot
be caused by the buffers. Besides, the measured binding af-
ﬁnity is not affected by the buffer used as long as the pKa of
the buffer is close to the pH of the solution and the buffer
itself does not interact speciﬁcally with any of the interacting
molecules. Very brieﬂy, if, for instance, the binding involves
a protonation of an ionizable group and, therefore, a de-
protonation of the buffer to keep the pH constant, the equi-
librium constant of the overall reaction is K ¼ [MLH1][B-]/
[M][L][BH], which does not depend on the buffer if the
concentration of base and acid forms are equal (that is, if the
pH is equal to the buffer pKa). In contrast, the measured
binding enthalpy by ITC will always contain a contribution
from buffer ionization (protonation or deprotonation) if there
is a net proton exchange between the complex and the bulk
solution. This net exchange is caused by a pKa change on
binding in certain ionizable groups elicited by a change in
their solvation microenvironment. For that reason, the buffer-
independent enthalpy must be calculated from a set of ex-
periments performed at the same conditions using buffers
with different ionization enthalpies. The buffer-independent
enthalpy will be composed of the intrinsic binding enthalpy
(that is, the overall enthalpy as a result of the net balance
between formation/breakdown of van der Waals, electro-
static, and hydrogen-bond interactions between the binding
partners and the solvent) plus the ionization enthalpy of the
groups involved in the proton exchange from the two binding
partners. Previous studies did not correct for this ionization
enthalpy, and our value (6 kcal mol1) is different from
those in other species (6 kcal mol1 in E. coli and 5 kcal
mol1 inM. capricolum (19–21)). Thus, the binding reaction
between EIsc and HPrsc is enthalpy-driven and in other spe-
cies is entropy-driven. Because the structure of the intact HPr
members seems to be similar, we do not know the exact
reasons for this difference in the thermodynamic parameters,
and they might rely on the different binding interfaces be-
tween EI:HPr complexes among the species (see below).
Finally, the binding of either the intact HPrsc or HPr9–30 to
EIsc could be nonspeciﬁc in light of the small value of the
afﬁnity constant. At this stage, we can rule out that possibility
because a control peptide, designed against inhibition of EIec
(33), also binds to EIsc, whereas two peptides designed
against two different proteins, with no structural or sequence
relationship to EIsc, did not show binding to EIsc (data not
shown). Then, although binding in the S. coelicolor PTS is
very weak, it is speciﬁc. These weak interactions are not
strange at all in cells because, when locally enriched or in-
volved in large multisubunit assemblies (as in HPrsc), they
may play key roles inmany important cellular events (38). For
instance, interactions between lymphocyte cell surface mol-
ecules are of the order of 104 to 106M and are necessary for
reversible cell-cell adhesion processes (39); furthermore,
some hit compounds designed against particular protein-
protein interfaces are in the range of the values of the afﬁnity
constants determined here for HPrsc andHPr9–30 (40). Finally,
it is interesting to note that weak interactions involving pro-
teins do not occur only with other proteins and/or peptides but
have also been observed in protein-lipid systems (41).
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There are, however, three reasons that could explain the
discrepancy among our KD and those previously reported
(19–21), and, in addition, they might provide insights into the
different values measured for the enthalpies among the dif-
ferent species. First, because there is a net proton exchange
between the complex and the bulk solution on binding, the
binding parameters are pH dependent. According to the value
of nH, a positive value indicates that the binding afﬁnity will
increase at lower pH, and it will decrease at higher pH. The
measurements described in E. coliwere carried out at pH 6.5,
and those in M. capricolum at pH 7.5 (19,20). Second, we
compared the structure of the complex between the N ter-
minus of EIec and the HPrec (17) (Protein Data Bank 3EZE)
with a model built for that complex between EIsc and HPrsc
(Fig. 5). The interface of the complex in E. coli has a larger
number of interactions (electrostatic and hydrogen-bonds)
than that of the modeled complex. Then, because a larger
number of interactions usually leads to a stronger afﬁnity, we
may conclude that the afﬁnity (and then the stability) of the
EI:HPr complex will be lower in S. coelicolor than in E. coli.
And ﬁnally, EI is a dimer, but the EI protein in any species
must be in the monomeric form to bind HPr (42–45). Its
dissociation constant is, in all the measured species so far, in
the range of micromolar at room temperature, except, in
Salmonella typhyimurium, where it reaches a nanomolar
value at 296 K (46); however, we have estimated that the
dissociation constant of EIsc at 298 K must be lower than
1 mM under our conditions (12), and then, lower than that of
EIec. Therefore, the interaction strength in the dimer is larger
in EIsc, and even if the intrinsic binding afﬁnities in EIsc and
the EIec for their corresponding HPr proteins were the same,
the apparent afﬁnity of HPr toward EI would be lower in S.
coelicolor. It is interesting to note, however, that peptides
against EIec (33) also bind to EIsc (one of our control peptides,
see above). Then, because the binding interfaces are so dif-
ferent among the bacterial species, we envisage that the
phosphorylation of sugars in S. coelicolor could be hampered
in the future by using modiﬁcations of HPr9–30, with a larger
afﬁnity than that described here. However, peptides or pep-
tide derivatives, which could be used interspecies, would
need a larger and more careful design and should be tested
against the different species.
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